Biomarkers reflecting brain amyloid beta accumulation (plasma Aß42/40 ratio), pathologic tau protein (p-tau231, p-tau181, p-tau217), and neurodegeneration (neurofilament light chain (NfL)) have advanced the diagnosis of AD and other neurodegenerative diseases [4–7]. The gene discussed is NEFL; the disease is neurodegenerative disease.